LORETO
VIDAUR TELLO
Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias
Madrid, EspañaPublications en collaboration avec des chercheurs de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (23)
2024
-
Author Correction: Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia (Scientific Reports, (2023), 13, 1, (17724), 10.1038/s41598-023-45007-4)
Scientific Reports
-
Impact of antimicrobial stewardship in organisms causing nosocomial infection among COVID-19 critically ill adults
European Journal of Internal Medicine, Vol. 119, pp. 93-98
2023
-
Lung microbiome on admission in critically ill patients with acute bacterial and viral pneumonia
Scientific Reports, Vol. 13, Núm. 1
2022
-
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21
2021
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science immunology, Vol. 6, Núm. 62
-
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
ERJ Open Research, Vol. 7, Núm. 1
2019
-
Factors associated with ventilator-associated events: an international multicenter prospective cohort study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 9, pp. 1693-1699
-
Human metapneumovirus as cause of severe community-acquired pneumonia in adults: insights from a ten-year molecular and epidemiological analysis
Annals of Intensive Care, Vol. 9, Núm. 1
2018
-
Assessing predictive accuracy for outcomes of ventilator-associated events in an international cohort: the EUVAE study
Intensive Care Medicine, Vol. 44, Núm. 8, pp. 1212-1220
-
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482
2017
-
Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort
Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 1, pp. 196-207
-
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Journal of Infection, Vol. 72, Núm. 2, pp. 143-151
2014
-
DALI: Defining antibiotic levels in intensive care unit patients: Are current ß-lactam antibiotic doses sufficient for critically ill patients?
Clinical Infectious Diseases, Vol. 58, Núm. 8, pp. 1072-1083
-
Decrease in Mortality in severe community-acquired pneumococcal pneumonia: Impact of improving antibiotic strategies (2000-2013)
Chest, Vol. 146, Núm. 1, pp. 22-31
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326
-
Early non-invasive ventilation treatment for severe influenza pneumonia
Clinical Microbiology and Infection, Vol. 19, Núm. 3, pp. 249-256
2012
-
Corticosteroid therapy in patients with primary viralpneumonia due to pandemic (H1N1) 2009influenza
Journal of Infection, Vol. 64, Núm. 3, pp. 311-318
-
Elevation of creatine kinase is associated with worse outcomes in 2009 pH1N1 influenza A infection
Intensive Care Medicine, Vol. 38, Núm. 7, pp. 1152-1161